« AstraZeneca Buys Ardea. And Who Else? |
| Merck Serono Cuts Back »
April 24, 2012
That's Some Fine Editorial Work There
Since I've mentioned the scientific publication business today, I thought I'd include this story from Retraction Watch as an example of what you're paying for when you pay Elsevier for quality control. When's the last time you saw a paper withdrawn because it "contains no scientific content"? Or noticed that the lead author's email contract address was at the domain "budweiser.com"?
+ TrackBacks (0) | Category: The Scientific Literature
POST A COMMENT
- RELATED ENTRIES
- How Not to Do It: NMR Magnets
- Allergan Escapes Valeant
- Vytorin Actually Works
- Fatalities at DuPont
- The New York TImes on Drug Discovery
- How Are Things at Princeton?
- Phage-Derived Catalysts
- Our Most Snorted-At Papers This Month. . .